B. Sweet Medspa does not directly sell prescription medication to consumers online or in-person. To receive prescription weight loss treatment, a medical evaluation by NP Kim Dayal or Dr. Shane Keller is required for prescription and administration. 

B. Sweet Medspa is also maintains LegitScript certification, which is a credential provided by LegitScript, a third-party organization that supports Google in evaluating and verifying the legitimacy and compliance of healthcare businesses worldwide.

Only businesses that LegitScript has certified as trustworthy are allowed to advertise on Google. 

BMI Calculator

Body Mass Index Calculator

Enter your height: metres inches

Enter your weight: kilograms pounds

Your BMI is: ?

BMI Categories:
Underweight = <18.5
Normal weight = 18.5–24.9
Overweight = 25–29.9
Obese = BMI of 30 or greater

 

When starting weigthloss medication, individuals may experience several effects related to its intended therapeutic action as well as potential side effects. Here's what people can generally expect when they begin taking semaglutide:

1. Blood sugar management: works to lower blood sugar levels by stimulating insulin secretion and reducing glucagon secretion, both of which help to control blood sugar levels. People may notice improvements in their blood sugar levels over time.

2. Weight loss: This effect can be noticeable, and some people may experience a significant reduction in body weight over time.

3. Decreased appetite:  People may find that they feel less hungry and have fewer cravings for food.

4. Injection site reactions: Redness, swelling, or itching at the injection site is common, especially initially. These reactions typically diminish over time.

5. Gastrointestinal effects: Nausea, vomiting, diarrhea, or abdominal discomfort are common side effects when starting the medication These symptoms often improve as the body adjusts to the medication.

6. Improved glycemic control: With consistent use, people typically experience better control over their blood sugar levels, leading to reduced risks of diabetes-related complications.

7. Routine monitoring: Regular monitoring of blood sugar levels and potential side effects is important when starting the medication. Healthcare providers may adjust the dosage or provide additional guidance based on individual responses to the medication.

8. Other potential effects: Some individuals may experience less common side effects such as hypoglycemia, increased heart rate, or, rarely, more serious issues like pancreatitis or kidney problems.

The weightloss medication prescribed is used primarily for the treatment of type 2 diabetes. Like any medication, it can have side effects. Common side effects of may include:

1. Nausea: This is one of the most commonly reported side effects. It usually occurs when treatment is initiated and may decrease over time.

2. Vomiting: Some individuals may experience vomiting as a side effect of semaglutide.

3. Diarrhea: Changes in bowel habits, including diarrhea, may occur with use.

4. Abdominal pain: Some people may experience abdominal discomfort or pain.

5. Constipation: In some cases, may cause constipation.

6. Decreased appetite: May lead to a decrease in appetite, which can result in weight loss.

7. Hypoglycemia: While less common compared to some other diabetes medications like insulin or sulfonylureas, the medication can cause low blood sugar levels (hypoglycemia), especially when used in combination with other blood sugar-lowering medications.

8. Injection site reactions: Redness, itching, or swelling at the injection site may occur.

9. Increased heart rate: Some individuals may experience an increased heart rate (tachycardia) while taking the medication.

10. Pancreatitis: In rare cases, may cause inflammation of the pancreas (pancreatitis), which can be serious.

11. Kidney problems: There have been reports of kidney problems associated with semaglutide use, including kidney failure.

12. Thyroid tumors: In animal studies, has been associated with an increased risk of thyroid tumors, although it's not clear if this risk applies to humans.